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Abstract
Background: The search for molecules against Mycobacterium tuberculosis is urgent. The mechanisms facilitating the intra-
macrophage survival of Mycobacterium tuberculosis are as yet not entirely understood. However, there is evidence showing
the involvement of host cell cytoskeleton in every step of establishment and persistence of mycobacterial infection.
Methodology/Principal Findings: Here we show that expression of ARPC4, a subunit of the Actin related protein 2/3 (Arp2/
3) protein complex, severely affects the pathogen’s growth. TEM studies display shedding of the mycobacterial outer-coat.
Furthermore, in infected macrophages, mycobacteria expressing ARPC4 were cleared off at a much faster rate, and were
unable to mount a pro-inflammatory cytokine response. The translocation of ARPC4-expressing mycobacteria to the
lysosome of the infected macrophage was also impaired. Additionally, the ARPC4 subunit was shown to interact with
Rv1626, an essential secretory mycobacterial protein. Real-time PCR analysis showed that upon expression of ARPC4 in
mycobacteria, Rv1626 expression is downregulated as much as six-fold. Rv1626 was found to also interact with mammalian
cytoskeleton protein, Arp2/3, and enhance the rate of actin polymerization.
Conclusions/Significance: With crystal structures for Rv1626 and ARPC4 subunit already known, our finding lays out the
effect of a novel molecule on mycobacteria, and represents a viable starting point for developing potent peptidomimetics.
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Introduction
About one third of the world population is latently infected with
Mycobacterium tuberculosis (Mtb). There has been no new drug
against Mtb for more than four decades, although recent
discoveries of small molecules show promise [1,2]. Knowledge of
the exact mycobacterial target protein for a particular drug is
nowadays considered crucial for understanding the mechanism of
action of anti-TB moieties. Moreover, the rapid spread of drug-
resistant Mtb has necessitated the requirement of target informa-
tion. However, discovery of new anti-TB molecules being a slow
and cumbersome process, a variety of strategies need to be
employed. One strategy is to use proteins and peptide libraries as a
starting point to discover entities that bind to specific Mtb targets.
Hits discovered this way can either be used on their own, or as a
template for discovering potent peptidomimetics. In a related field,
numerous peptidomimetic inhibitors of the Hep C protease have
been discovered and two among them, Telaprevir and Bocepravir,
have recently entered the market [3,4].
As an ongoing effort to pursue such a strategy, we report here
the discovery, that a known human protein, the ARPC4 subunit of
the human Arp2/3 complex, severely affects Mtb growth and
shows significant alterations in immune response ex vivo. Employ-
ing the rational approach means that the Mtb target of ARPC4 is
known as well. It is the essential protein Rv1626, the knowledge of
the structure of which has linked it to several putative functions.
Once the bacillus finds its niche in a macrophage, it secretes
proteins in its milieu to make the environment habitable. Rv1626
is one such secretory protein that has been predicted to perform
the role of a Two-Component System (TCS) response regulator,
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with Rv3220c as its cognate histidine kinase [5,6]. Both these
proteins are conserved across all mycobacterial species and exhibit
strong expression after 18 hours of intracellular growth that starts
declining after 110 hours, suggesting that these proteins are
important during the early stages of Mtb growth [7,8]. Rv1626
also shows high structural similarity to a known transcription anti-
termination factor, AmiR from Pseudomonas aeruginosa [9].
Rv1626 is enlisted in Rubin’s list of essential proteins of Mtb but
its functions are still a matter of speculation [10]. As Rv1626 is
constitutively synthesized and secreted out by the bacterium
[5,8,11,12], some of its functions should rationally also be
extracellular. Indeed, in a comprehensive and seminal study
Belisle and co-workers showed Rv1626 to be one of the hundred
odd proteins that constitute the secretory proteome of Mtb, as they
were able to purify Rv1626 from the culture filtrate using a
combination of anion exchange chromatography and SDS-PAGE,
followed by electroelution [11].
We found that the ARPC4 subunit of the mammalian
cytoskeletal protein Arp2/3 interacts with Rv1626, and the
expression of ARPC4 inside mycobacteria causes severe effects
that could be because of this interaction. Intriguingly, we find that,
like other Arp2/3 interacting pathogenic proteins [13–15],
Rv1626 enhances the actin polymerization efficacy of Arp2/3.
We speculate on the possibility of the interaction between
mycobacterial Rv1626 and mammalian Arp2/3 being of the same
significance as it is for other intracellular pathogens that synthesize
proteins that directly or indirectly modulate host cell cytoskeleton
for their survival and perpetuation. Also, as ARPC4 expression
inside Mtb causes significant deleterious effects on its survival and
infectivity, structural analogues of ARPC4 can be explored for
development of anti-TB drug candidates.
Materials and Methods
In vivo Protein-Protein Interaction: Bacterial Two-Hybrid
Studies
BacteriomatchTM two-hybrid system kit and human lung cDNA
library (cloned in pTRG vector) were purchased from Stratagene,
USA. The full length rv1626 gene was PCR amplified from Mtb
H37Rv genomic DNA using forward and reverse primers (Table 1)
and following subcloning into pGEMT easy vector, was cloned in
modified pBT vector, pBTnn [16].
The reporter E. coli strain was co-transformed with equal
amounts (250 ng each) of Rv1626-pBTnn and human lung cDNA
library and plated on X-Gal indicator plates containing kanamycin
(50 mg/ml), chloramphenicol (30 mg/ml), tetracycline (12.5 mg/
ml), X-Gal (80 mg/ml), Isopropyl b-D-1-thiogalactopyranoside,
IPTG (25 mM), and phenylethyl b-D-thiogalactoside (200 mM).
Plasmids pBT-LGF2, pTRG-Gal11p (manufacturer provided
positive controls) and empty pBTnn plasmid (for negative control)
were co-transformed in proper combinations. Positive interactions
were judged by the blue colour of the colonies obtained and
further verified by repeated clonings and co-transformations. All
interactions were further verified by liquid b-galactosidase assay
performed as described earlier [17] and the statistical significance
of the interactions was evaluated by Student’s t-test.
Cloning of ARPC4 Gene
Full length ARPC4 gene was re-cloned into modified pTRG
vector, pTRGnn [16]. The gene was amplified from
ARPC4pTRG (fished out from the lung cDNA library) using
forward and reverse primers (Table 1), the PCR product was
SnaBI digested, and was ligated in SnaBI-cut pTRGnn plasmid.
Cloning of Rv1626 and ARPC4 for Protein Expression
In a manner similar to above, rv1626 gene was PCR-amplified
(primer details in Table 1), SnaBI-digested and ligated into SnaBI-
cut Stop-pET28 and pGEX4T3nn vectors [16]. These vectors,
upon induction, produce tag-less Rv1626 protein and a fusion
protein of Rv1626 with an N-terminal GST tag, respectively. Also,
SnaBI-digested ARPC4 PCR product was cloned into SnaBI-
digested Bla1cut-pET28a [16]. This vector, upon induction,
produces ARPC4 protein with a C-terminal hexa-Histidine tag
(ARPC4-His6x).
Protein Expression and Purification of ARPC4-His6x
Exponentially growing E. coli BL21 (DE3) cells harbouring
ARPC4Bla1cut-pET28a were induced with 1 mM IPTG for 3
hours at 37uC. Harvested cell pellet was washed with PBS
(137 mM NaCl, 2.7 mM KCl, 10 mM NaH2PO4 and 2 mM
K2HPO4, pH 7.4), resuspended in lysis buffer (6 M Guanidine
hydrochloride, 10 mM Tris, 100 mM sodium phosphate buffer,
150 mM NaCl, 0.1% Tween-20 and 0.01% CHAPS, pH 7.2),
and lysed by sonication. Clear cell lysate was incubated with lysis
buffer-equilibrated Qiagen Ni-NTA agarose beads for 2 hours and
protein was purified pH-based elution at room temperature.
Column was washed with lysis buffer, wash buffer 1 (10 mM Tris,
100 mM sodium phosphate buffer, 50 mM NaCl, 8 M Urea,
pH 6.3) and wash buffer 2 (10 mM Tris, 100 mM sodium
phosphate buffer, 8 M Urea, pH 5.9). The resin bound proteins
were eluted with elution buffer (10 mM Tris, 100 mM sodium
phosphate buffer, 8 M Urea, pH 4.5) and dialyzed against storage
buffer (50 mM L-glutamate, 50 mM L-arginine in 20 mM sodium
Table 1. Sequences of the DNA primers used for PCR amplification of various genes described in the present study.
Primer Name Primer Sequence
ARPC4 forward 59-CCG AAT TCT ACG TAA TGA CTG CCA CTC TCC GCC CCT ACC TG-39
ARPC4 reverse 59-CCG AAT TCT ACG TAA AAA TTC TTA AGG AAC TCT TCA GCC ACA A-39
rv1626 forward 59-CCT ACG TAA TGA CCG GCC CCA CCA CCG ACG CCG A-39
rv1626 reverse 59-CCT ACG TAG GTG TCT TTG GGT GTT CCG AGG GTT-39
bfrB forward 59-ACA GAA TAC GAA GGG CCT AA-39
bfrB reverse 59-ACG AAG GTC GCG GTC GAG CA-39
16S rrna forward 59-GCA CCG GCC AAC TAC GTG-39
16S rrna reverse 59-GAA CAA CGC GAC AAA CCA CC-39
doi:10.1371/journal.pone.0069949.t001
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acetate buffer, pH 5.0) to remove urea and was stored at 220uC
till further use.
Protein Expression and Purification of Rv1626
E. coli BL21 (DE3) (Novagen) cells, harbouring Rv1626-Stop
pET28 vector, were grown till mid-log phase and induced with
1 mM IPTG for 3 hours with constant shaking at 37uC. Cells were
harvested and the pellet was washed with PBS buffer. Cell pellet
was resuspended in (1% of the original culture volume) lysis buffer
(4 mM dithiothretol, 20 mM Tris-HCl pH 8.0) that was supple-
mented with 2 mM PMSF and sonicated till a clear lysate was
obtained. This lysate was then centrifuged to obtain a clear
supernatant that was transferred into fresh tubes. Rv1626 protein
was purified by the method described earlier [9]. Briefly, the clear
lysate was run through a 5.0 ml HiTrap Q HP column (GE
Healthcare Life Sciences) equilibrated in Buffer A (50 mM KCl,
2 mM dithiothretol, 20 mM Tris-HCl pH 8.0) and a 20 column
volume continuous gradient was run from Buffer to Buffer B (1 M
KCl, 2 mM dithiothretol, 20 mM Tris-HCl pH 8.0) using the GE
Healthcare Life Sciences Pharmacia Biotech AKTA FPLC
pumping system. Rv1626 protein eluted at around 400 mM
KCl. Relevant fractions were pooled and concentrated to 2 ml
volume using Vivaspin 15 centrifugal concentrator (VivaProducts).
The protein was further purified by gel permeation chromatog-
raphy using a HiLoad 16/60 Superdex 75 pg column (GE
Healthcare Life Sciences) equilibrated in buffer A. Peak fractions
were pooled, dialyzed against PBS and stored at220uC in aliquots
till further use.
Protein Expression and Purification of GST-Rv1626
Exponentially growing E. coli BL21 (DE3) (Novagen) cells
harbouring Rv1626-pGEX4T3nn were induced with 1 mM
IPTG for 16 hours at 18uC. Harvested cells were washed with
PBS buffer, resuspended in PBS buffer supplemented with 2 mM
PMSF (phenylmethanesufonyl fluoride) and sonicated till a clear
lysate was obtained. Clear cell lysate was incubated with PBS-
equilibrated Glutathione Sepharose-4B beads (GE Healthcare Life
Sciences) at 4uC overnight. Following PBS washes, resin bound
proteins were eluted using elution buffer (10 mM reduced
glutathione in 50 mM Tris-Cl, pH 8.0) and dialyzed against
PBS and stored at 220uC in aliquots till further use.
In vitro Protein-Protein Interaction
Protein-protein interaction in vitro was confirmed by dot Far-
Western Blot analyses and were performed according to protocols
described previously [18,19].
Rv1626 and ARPC4. Purified ARPC4-His6x, GST and GST-
Rv1626 proteins were immobilized on four strips of nitrocellulose
membrane (1 mg protein per spot). The strips were incubated in
blocking solution, 5% non-fat dry milk and 2% polyvinyl
pyrrolidone (PVP) in PBS-T buffer (1% Tween-20 in PBS), for 2
hours at room temperature. After three washes with PBS-T, strips
(a) and (c) were incubated overnight in 1 mg/ml solutions of GST-
Rv1626 and GST respectively in cold room with constant shaking.
1 mg/ml protein solutions were prepared in a solution of
composition 1% PVP and 2.5% non-fat dry milk in PBS-T. The
strips were then probed with anti-GST antibodies (Sigma). The
control strips, (b) and (d), were directly probed with anti-pentaHis
(Qiagen) and anti-GST antibodies, respectively. HRPO-conjugat-
ed secondary antibodies (goat anti-mouse IgG) were purchased
from Calbiochem and all the strips were developed using TMB
(Sigma) as substrate.
Rv1626 and Arp2/3. Arp2/3 (Cytoskeleton Inc., USA) and
BSA (Sigma) proteins were immobilized on two strips of
nitrocellulose membrane (1 mg protein per spot). The strips were
incubated in blocking solution for 2 hours at room temperature as
above. After three washes with PBS-T, the strips (a) and (b) were
incubated overnight in 1 mg/ml solution of GST and GST-
Rv1626, respectively in cold room with constant shaking. Protein
solutions were made just as above. The strips were subsequently
probed with anti-GST antibodies, followed by HRPO-conjugated
secondary antibodies and developed with TMB.
Actin Polymerization Assay
Actin polymerization kit was acquired from Cytoskeleton Inc.,
USA, and the assay was performed as per the instruction manual
and as described earlier [15]. Briefly, actin polymerization was
monitored as enhanced pyrenyl-actin fluorescence. Pyrene-
labelled rabbit muscle actin in G-buffer (0.2 mM CaCl2,
0.2 mM ATP, 5 mM Tris-HCl pH 8.0) was pre-cleared by
centrifugation. To this pre-cleared G-actin (3.6 mM, pyrene-
labelled), Rv1626 (500 nM), VCA domain (400 nM; Cytoskeleton
Inc.), an unrelated protein (500 nM) and Arp2/3 (10 nM) alone or
in the combinations were added and the baseline was stabilized
before initiating the polymerization by addition of the actin
polymerization buffer (50 mM KCl, 2 mM MgCl2, 1 mM ATP,
0.5 mM dithiothretol, 1 mM EGTA, 0.1 mM CaCl2 10 mM Tris-
HCl pH 7.5). Fluorescence measurements were made with
Molecular Devices SpectraMax M2 Spectrofluorimeter at 25uC,
with excitation and emission wavelengths set at 350 and 407 nm
respectively.
Cloning of ARPC4 in Mycobacterial Expression Vector
pVV16
The ARPC4 gene was amplified from original lung cDNA
library clone, and the SnaBI digested PCR product was cloned into
SnaBI-digested Mtb shuttle vector pVV16 to generate
ARPC4pVV16 [20]. One of the positive clones was used for
further transformation in Mtb H37Rv by electroporation. Positive
mycobacterial clones were identified by PCR following plasmid
DNA extraction from Mtb.
Confirmation of ARPC4 Gene Expression in H37Rv
The expression of ARPC4 protein in H37Rv cells was
confirmed by checking the synthesis of ARPC4 gene transcript.
For this, total RNA was extracted from exponentially growing
cultures of Mtb H37Rv (control) and H37Rv harbouring the
ARPC4pVV16 plasmid (H37Rv/ARPC4) and reverse transcribed
to obtain cDNA (as per the methods described below). This cDNA
was PCR amplified using ARPC4 forward and reverse primers
and the product was checked on 1% agarose gel.
RNA Extraction from Mtb
Total RNA was extracted as described previously [20].
Growth Curve Studies of Mtb
Mtb harboring ARPC4pVV16 (H37Rv/ARPC4) or pVV16
(H37Rv/pVV16) vectors were grown in 10 ml Middlebrook 7H9
broth (DifcoTM, BD) supplemented with 10% ADC (BBLTM, BD),
0.05% Tween-80, 0.2% glycerol, and kanamycin (25 mg/ml) at
37uC and constant shaking till stationary phase was reached.
Optical density of the culture was measured at 600 nm using
Lambda 35 spectrometer (PerkinElmer) and equal numbers of
cells from each culture were freshly inoculated in 30 ml flask
containing fresh 7H9 kanamycin broth such that the initial O.D.
of the culture is 0.05. Cells were allowed to grow at 37uC with
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constant shaking. Optical density of each culture was measured
and recorded after every 24 hours.
CFU Count
To corroborate the growth curve results a Colony Forming
Units or CFU count was performed. At time-points of 0, 7 and 14
days, four dilutions (made in PBS) of the H37Rv/ARPC4 and
H37Rv/pVV16 cultures, being grown and monitored for growth
curve analyses, were plated on 7H11 agar (DifcoTM, BD) plates
supplemented with 0.5% glycerol and 10% OADC (BBLTM, BD),
such that the highest dilution would give approximately between
10–100 colonies. The plates were incubated at 37uC for 15 days
before the number of colonies were counted and recorded.
Transmission Electron Microscopy
Mtb H37Rv cells and H37Rv cells harboring ARPC4pVV16
were grown at 37uC with constant shaking till mid-log phase. Cells
were harvested and fixed with 2% paraformaldehyde solution as
described earlier [21], were allowed to adsorb on a carbon coated
300 square mesh copper grid (Electron Microscopy Sciences,
USA) and air dried. Samples were then stained with 1% uranyl
acetate for 30 seconds and photographed using a FEI Tecnai 12
Electron Microscope.
Real Time PCR
100 ng RNA from control (H37Rv) and test (H37Rv/ARPC4)
samples was reverse transcribed using RevertAidTM H minus first
strand cDNA synthesis kit (Fermentas) with random hexamer
primers in a total volume of 10 ml. The reaction mixture was
incubated in a thermocycler at 25uC for 5 minutes, 42uC for 60
minutes, 85uC for 5 minutes and finally cooled to 4uC.
Real time PCR was performed using Maxima SYBR Green/
Flourescein qPCR master mix (Fermentas) in a total reaction
volume of 25 ml consisting of 0.3 mM of each primer (forward and
reverse primers of Rv1626, BfrB and 16S rRNA genes; Table 1),
12.5 ml of 26Maxima SYBR Green/Flourescein qPCR master
mix, and 5 ml of diluted cDNA template (equivalent to 5 ng RNA).
Amplification was performed in a MiniOpticon (BioRad) thermo-
cycler in the following conditions: (i) an initial denaturation step of
3 minutes at 95uC; (ii) 40 cycles, each consisting of 30 seconds at
95uC, 30 seconds at 60uC, and 30 seconds at 72uC. Fluorescence
was measured at the end of the elongation step of each cycle. A
melt curve analysis was performed between 55uC and 95uC with
an increment of 0.5uC per 30 seconds. PCR products were also
checked on 1% agarose gel. Data was analyzed using comparative
Ct method as described earlier [22]. 16S rrna was used as an
internal control gene for normalization and an unrelated bfrB gene
was included as a negative control.
Murine Macrophage Infection Studies
Mice. C57BL/6 male mice at 6–8 weeks of age were used
throughout the study following institutional ethical committee
guidelines. All animal experiments were conducted in accordance
with guidelines approved by the Institutional Animals Ethics
Committee of ICGEB, New Delhi, India and Department of
Biotechnology (DBT), Government of India. Mice were housed
under barrier conditions in a Biosafety Level III laboratory.
CFU Counts Post-infection
2.5 ml of autoclaved thioglycolate was given to 6 to 7 weeks old
male C57BL/6 mice and kept for 4 days in pathogen free
environment. On day 5, they were sacrificed and intraperitoneal
macrophages were isolated. Macrophages were counted and
16106 cells were seeded in 12 well plates (Nunc, USA) with
10% RPMI 1640 (Gibco, Invitrogen, UK). Cultured cells were
kept for 24 hours and then infected with exponentially growing
culture of Mtb H37RV and Mtb H37RV/ARPC4 at an MOI of
10. At specific time-points (0, 24, 48 and 72 hrs), the macrophages
were lysed using 0.04% SDS in 7H9 medium and four dilutions of
the lysate were plated on 7H11 agar plates. The CFU counts were
recorded after 15 days.
Staining for Flow Cytometry for Cytokine Analysis and
Cell Surface Markers
Following antibodies were acquired: Anti-CD11b (clone: M1/
70)-APC, anti-CD11c (clone: N418)-FITC, anti-TNF-a (clone:
MP6-XT22)-PE, anti-IL-6 (clone: MPS-20F3)-PE, anti-IL-12
(clone: C15.6)-PE, anti-IL-22 (clone: Poly5164)-PE, anti-IL-10
(clone: JES5-16E3)-PE, anti TGFb (clone: TW7 -16B4 ) PE, IL1a
(clone: ALF-161) PE,(all from Biolegend, USA),CD80 (clo-
ne:1610A1) PE, MHCII (clone: M5/114.15.2) PE,CD86 (clone:
P03.1) PE, CD1 4(clone: sa2-8) PE, PD1 (clone: J43) PE, CD54
(clone: YN1/1.7.4) (PE all from eBiosciences,USA and PI from
BD pharmingenTM, USA).
Infected murine intraperitoneal macrophages (infected as
described above) were cultured for 48 hours and used for surface
staining. For intracellular staining 16106 cells were cultured per
well in 24-well plates (Nunc, USA) and activated with 50 ng/ml
phorbol 12-myristate 13-acetate (PMA) and 500 ng/ml ionomycin
(Sigma, USA) overnight, and 10 mg/ml Brefeldin A (eBiosciences,
USA) was added during the last 6 hours of culture. Cells were
washed twice with PBS and stained with antibodies directed
against surface markers. After staining, cells were washed again
with PBS and fixed with 100 ml fixation buffer (eBiosciences, USA)
for 30 minutes, then re-suspended in 200 ml permeabilization
buffer (eBiosciences, USA) and stained with fluorescent labelled
anti-cytokine antibodies. Fluorescence intensity of fluorochrome-
labelled cells was measured by flow cytometry (FACS CantoTM II,
BD Biosciences, USA). Cell viability dye (PI) was added to the cells
15 minutes before analyzing the cells by flow cytometry. FACS
Diva was used for acquiring the cells and final data analysis was
performed by Flow Jo (Tree star, USA).
Confocal Microscopic Studies
For confocal microscopic studies, the infection was carried out
as above with minor changes. The mycobacterial cells were FITC-
labeled and washed before using them for infecting macrophages
seeded on coverslips. The infection was done at an MOI of 5.
FITC (Sigma, USA) binds non-specifically to the mycobacterial
cell surface and stains them green. The coverslips were then
washed with PBS and fixed with 2.5% paraformaldehyde for 20
minutes followed by a wash with PBS. The cells were
permeabilized by treatment with 0.1% NP-40. The coverslips
were then stained with antibodies against LAMP-1 (anti-mouse
CD107a, BD PharmingenTM, USA), followed by Alexa Fluor 594
goat anti-rat antibodies (Invitrogen, USA). The coverslips were
mounted on glass slides using moviol and observed using 488
(green) and 560 (red) nm lasers on Nikon A1R microscope.
Results
Expression of ARPC4 Significantly Affects Mtb Growth in
Axenic Culture
H37Rv Mtb was transformed with ARPC4pVV16 and 3
individual colonies were picked and analyzed by plasmid mini-
prep followed by PCR for the presence of the plasmid DNA.
Expression of ARPC4 in Mtb was confirmed by checking the
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transcription of ARPC4 mRNA; a clear band was seen in the
H37Rv/ARPC4 sample.
To study the effect of ARPC4 on general growth of Mtb, a
growth curve analysis was performed wherein optical density of
H37Rv/ARPC4 and H37Rv/pVV16 (empty vector) cultures was
measured after every 24 hours and plotted against time (in days).
The experiment was repeated thrice. Similar pattern was observed
each time. It was found that the Mtb harbouring ARPC4pVV16
showed severe retardation in growth when compared with the
vector control (figure 1A). The difference – eight to ten-folds –
became evident as soon as the cells entered log phase and lasted till
stationary phase. As a confirmation of the growth-curve study, a
CFU count was carried out. At three different time points, i.e., at
day 0, 7 and 14, the culture was removed under sterile conditions
and four different dilutions were plated on 7H11 agar plates.
Mycobacterial colonies were counted after 10–15 days and the
number was plotted against time (in days). A significant reduction
in the mycobacterial CFUs was observed in the culture of H37Rv/
ARPC4, in comparison to that of H37Rv/pVV16 (figure 1B),
thereby corroborating the growth-curve study.
Expression of ARPC4 Protein in Mtb Alters the Cell
Morphology
The deleterious effects of ARPC4 expression in Mtb, as
observed by the growth-curve and CFU counts, led us to
investigate its effect on cell morphology. TEM studies showed
that, compared with the control (H37Rv) sample, H37Rv/ARPC4
cells are smaller in size and show shedding and thinning of the
outer coat of the cell (figure 1C b and c). The mycolic acid layer is
non-contiguous and is coming off the cell surface as thread-like
structures, whereas the control H37Rv cells have a thick and
continuous cell coat (figure 1C a).
Expression of ARPC4 Down-regulates rv1626 Gene
Expression
To underline the cause of the effect, namely the interaction of
ARPC4 and Rv1626 proteins, real-time PCR was performed
wherein rv1626 transcript levels of H37Rv/ARPC4 were com-
pared with those in control H37Rv cells. 16S rRNA gene was used
as the normalization internal control. Rv1626 gene expression was
found to be approximately 6-fold down-regulated in H37Rv/
ARPC4 cells. An unrelated gene, bfrB was also used as a control
(figure 1D) which was not affected significantly.
Recombinant H37Rv/ARPC4 is Incompetent for its
Survival in Macrophage
Having witnessed the difference in growth in vitro, as well as
abrupt morphological changes, we sought to determine the
survival of recombinant H37Rv/ARPC4 in macrophages, the
natural host for Mtb. We observed that H37Rv/ARPC4 cleared
rapidly, whereas wild type Mtb continued to grow (figure 2A). To
further test whether rapid clearance is due to enhanced
macrophage activation, we determined cytokine production in
infected macrophages. We found that H37Rv/ARPC4 infected
macrophages produce significantly less cytokines than those
macrophages infected with wild type Mtb (figure 2B). To further
ensure that macrophages are indeed not activated, we determined
expression of MHCII, CD14, CD54, CD80 and CD86. As
expected we noticed that these markers are not up-regulated, while
wild-type Mtb infected macrophages resulted in the up-regulation
of these molecules (figure 3A). These observations indicate that
faster clearance of the mutant was not due to the altered
macrophage activation, but rather its intrinsic inability to adapt
to host cellular environment.
Confocal Microscopy shows Inhibited Translocation of
H37Rv/ARPC4 to Phagolysome
To further study of mechanism of faster clearance of H37Rv/
ARPC4 in macrophages, we analysed intra-compartmental
localization by confocal microscopy. As expected number of
H37Rv/ARPC4 was found to be dramatically less within
macrophages as compared to that of wild type H37Rv strain in
all the time-points measured (figure 3B a–d). The same is
represented graphically as a comparison of the percentage of
infected macrophage cells for the total number of macrophages
counted (figure 3B e). We further noticed that very few H37Rv/
ARPC4 cells are within phago-lysosomal compartment (figure 3B
b–d). A quantitative measure is presented (figure 3B f).
Rv1626 Interacts with ARPC4 Subunit of Arp2/3 Protein
In order to elucidate the role of Rv1626, a bacterial two-hybrid
system was used to fish out interaction partner(s) of the secretory
protein from the human lung cDNA library. A distinctly blue-
colored colony was isolated. Sequencing result followed by a
BLAST search identified the interacting partner as the ARPC4
subunit of the Arp2/3 protein complex. The interaction was
confirmed by several rounds of plasmid segregation followed by
co-transformation and re-cloning of ARPC4 in pTRGnn vector
followed by re-cotransformation (figure 4A).
For a quantitative estimation of the strength of interaction of
Rv1626 and ARPC4, liquid b-galactosidase assay was performed.
The enzyme activity in case of Rv1626 and ARPC4 interaction
was found to be comparable to that of a known mycobacterial
protein-protein interaction, that of CFP10 and ESAT6 proteins
which are both mycobacterial proteins and are well documented
to form a tight heterodimer [23], showing that the interaction of
Rv1626 and ARPC4 is strong (figure 4B).
In vitro Interaction of Rv1626 and ARPC4 Confirmed by
Dot Far-Western Analyses
The ARPC4:Rv1626 interaction was confirmed in vitro by Dot
Far-Western experiments. For this, ARPC4 was expressed as a C-
terminal His-tagged protein and purified using a Ni-NTA agarose
column (figure 5A), while Rv1626 was expressed as an N-terminal
GST-tagged protein, GST-Rv1626, and purified using Glutathi-
one Sepharose-4B resin (figure 5B). ARPC4 was immobilized onto
a strip of nitrocellulose membrane and the strip incubated with
GST-Rv1626. When probed with anti-GST antibodies, Rv1626
could be detected over the ARPC4 spot, confirming the
interaction between ARPC4 and Rv1626 in vitro. False or
erroneous interaction because of the 26 kDa GST tag was ruled
out by replication of the experiment wherein incubation of the
strip was carried out with GST. GST could not be detected on this
control strip. All the positive control dots of immobilized GST/
GST-Rv1626 proteins were detectable on both the strips,
nevertheless (figure 5C).
Rv1626 Interacts with Arp2/3 Complex
The ARPC4 protein is a subunit of the large 224 kDa seven
subunit Arp2/3 complex. Therefore, we wanted to further
investigate whether the interaction of Rv1626 is confined only to
the ARPC4 subunit or whether it is also able to interact with the
entire Arp2/3 complex as well. For this, Rv1626 protein was
purified according to the method described earlier [9] and Dot
Far-Western analyses were performed. In this experiment, when
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Arp2/3 and BSA were immobilized on a nitrocellulose membrane
strip and the strip was incubated with GST-Rv1626, upon probing
with anti-GST antibodies, GST-Rv1626 was detected on the dot
corresponding to Arp2/3 while no protein was detected bound to
BSA. A control strip was incubated with GST just as above; no
protein-protein interaction was detected on this strip (figure 6A).
Employing traditional pull-down and co-immunoprecipitation
assays for confirming the in vitro interaction of Rv1626 with the
entire Arp2/3 complex were unsuccessful. It could be that the
interaction of Rv1626 with ARPC4 in context of the entire seven
subunit Arp2/3 protein complex may be altered, even transient,
and therefore undetectable by conventional methods, given that
these in vitro tools depend primarily on the high stability and
strength of the interaction under study [24].
Figure 1. Effect of ARPC4 on the growth of M. tuberculosis. A. An individual colony each from mycobacteria harbouring either ARPC4pVV16
(H37Rv/ARPC4) or pVV16 empty vector (H37Rv/pVV16) was picked for growth curve analysis. Optical density of both cultures was measured at
600 nm. Mean6s.d values are plotted against time (in Days). A similar growth curve pattern was observed each time the experiment was repeated.
Triangular data points represent OD600 values of H37Rv/pVV16 samples (control); circles represent OD600 values of H37Rv/ARPC4 samples. B. Cultures
were grown in 7H9 medium at 37uC with shaking under axenic conditions. The figure shows result of CFU counts of H37Rv/ARPC4 and H37Rv/pVV16
at days 0, 7 and 14. A significant decline in the survival of mycobacteria carrying ARPC4pVV16 was observed in comparison to the vector control. C.
Effect of ARPC4 expression on cell morphology growth of M. tuberculosis. Transmission electron micrographs of H37Rv (panel a) and mycobacterial
cells harboring ARPC4pVV16 (H37Rv/ARPC4) (panels b and c). D. Relative fold change in the transcript levels of rv1626 and bfrB genes. The rv1626
gene (dark grey) was found to be significantly down-regulated (6-fold) in H37Rv/ARPC4 cells when compared with the H37Rv mycobacterial cells,
whereas the unrelated bfrB gene (light grey) expression was not much perturbed. The 16S rRNA gene was used as the normalization internal control.
Experiment was performed in triplicates.
doi:10.1371/journal.pone.0069949.g001
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Figure 2. Infection of murine macrophages with H37Rv/ARPC4 mycobacterial strain. A. CFU count showing the bacterial load in
macrophages infected with H37Rv/ARPC4 and wild-type H37Rv. The infected macrophages were lysed at 0, 24, 48 and 72 hour time-points post-
infection and four dilutions of the released mycobacterial cells were plated on 7H11 agar plates. CFU were counted and recorded after 15 days of
plating. B. The plots show the cytokine milieu in macrophages. Macrophages were cultured and activated with 50 ng/ml phorbol 12-myristate 13-
acetate (PMA) and 500 ng/ml ionomycin overnight, and 10 mg/ml Brefeldin A was added during the last 6 hours of culture. Cells were then
intracellularly stained with anti-IL22, -TGFb, -IL10, -IL12, -IL6, TNFa, and IL1a antibodies. Cells were acquired by flow cytometer. Data are shown as
mean6STDEV and Student’s t-test was applied for estimating significance between two groups and the * denotes p,0.01.
doi:10.1371/journal.pone.0069949.g002
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Rv1626-Arp2/3 Interaction Enhances Actin
Polymerization Rate
It has been shown for many pathogenic proteins that their
interaction with Arp2/3 increases its efficiency of actin polymer-
ization. In the assay, the enhanced fluorescence resulting from
pyrene Globular- or G-actin (monomer) polymerizing to form
pyrene F-actin (Filamentous actin) is measured using a fluorimeter
to follow the polymerization over time. We decided to investigate
whether Rv1626 is able to enhance actin polymerization in the
presence of Arp2/3. Polymerization of actin was monitored in
presence of both Arp2/3 and Rv1626, alone and in combination
(figure 6B). A buffer control (PBS), a positive control (GST-tagged
VCA (Verprolin, cofilin, acidic) domain of human WASP protein)
and a negative control (unrelated protein) were also run. The rate
of polymerization of actin in PBS was observed to be nearly the
same as in presence of the unrelated protein with Arp2/3 and both
these were only marginally lower than the polymerization induced
by Arp2/3 alone. This confirms the fact that Arp2/3 alone cannot
polymerize actin very efficiently without being activated by an
NPF (nucleation promoting factor). On the other hand, actin
polymerization was found to be much higher in presence of both
Rv1626 and Arp2/3 proteins when in combination. Actin
polymerization in the positive control – VCA domain with
Arp2/3– was found to be far higher than that with both proteins
alone.
Discussion
Expression of ARPC4 inside Mtb causes severe growth
retardation, comparable to that caused by Granulysin on Mtb
cultures, or indeed of Mtb strains where essential genes like glnR
are knocked out [25]. The 6-fold down-regulation of rv1626 gene
expression in ARPC4-expressing H37Rv cells and the extent of
growth retardation because of it projects Rv1626 as a potential
drug target. As discussed earlier, structural predictions indicate
Rv1626 as a possible transcription anti-terminator. It is quite likely
that, by virtue of its interaction with Rv1626, ARPC4 sequesters
Rv1626 and makes it unavailable for the anti-termination
function. This unavailability may also affect the expression levels
of a multitude of genes. This could be further investigated by DNA
microarray experiments that are currently underway in our
laboratory.
The TEM results show significant differences between the
morphology of wild type and ARPC4-expressing strains, for
example the extensive shedding of the cell wall, an outcome that
could result in significant loss of cell surface proteins. These
proteins play protective role for the bacterium to mask it from the
host defence system [26]. To corroborate this, macrophage
infection studies were carried out which indicated H37Rv/
ARPC4 to have greatly lost its infectivity as well as persistence
in macrophages. It is being cleared off from the macrophages with
such rapidity that cytokine production is not being triggered and
the host cells are not activated to mount any immunogenic
response. Furthermore, the confocal microscopy results show that
H37Rv/ARPC4 bacteria are not able to translocate to the
lysosomal compartment. This indicates that although the cytokine-
stimulated macrophage phagocytic pathway is not being triggered,
the ARPC4-expressing mycobacteria are in itself incapable of
survival and persistence within the macrophages.
Mtb has approximately 4000 protein coding genes (JCVI-CMR:
Mycobacterium tuberculosis CDC1551 Genome). For a pathogen this is
a rather conservative number, as a pathogenic bacteria has to take
care not only of its own cellular functions but also has to devise
ways to tackle the defence mechanisms of the host. Recent studies
are bringing forth the fact that this apparent shortcoming is
compensated through many of its proteins performing a multitude
of functions, i.e. the proteins are multi-functional or are ‘moon-
lighting’ proteins.
Predictions based on the reported structure indicate Rv1626
protein to be a phosphorylation-dependent transcription anti-
terminator [9]. Based on our studies, an additional possible role for
Rv1626, that of aiding Mtb to establish infection in macrophages,
may be worthy of further investigation. Our experiments show
that mycobacterial Rv1626 interacts with the ARPC4 subunit of
Arp2/3, and in turn also with the entire complex itself, a complex
that plays a vital role in the maintenance of the mammalian cell
cytoskeleton. Arp2/3 is an actin polymerizing protein complex
and is involved in all the motile activities of the cell that require
dynamic actin filament assembly, like cell migration, endocytosis,
vesicle trafficking, cytokinesis etc [27]. In cells Arp2/3 is the main
factor that regulates the state of actin. In actin polymerization
assay it was seen that the rate of spontaneous condensation actin to
form filamentous actin was nearly the same as when in the
presence of Arp2/3. This confirms the requirement of an activator
of Arp2/3 to bring about significant polymerization. Actin
polymerization in the presence of both Rv1626 and Arp2/3 as a
combination was seen to be much higher than in presence of both
the proteins separately. The ability of Mtb to alter host cell
cytoskeleton has been reported previously [28]. In the case of
Mycobacterium marinum, it has been reported that the bacterium not
only breaks free from the phagosome and enters the cytoplasm of
the infected macrophages but also uses actin-based motility for
Figure 3. Activation of infected macrophages and inter-compartmental localization of mycobacteria within A. The plots depict
reduced activation of H37RV/ARPC4 infected macrophages. a) Percentage of cells expressing PD1 among CD11B+ cells is shown in the dot plots with
mean6STDEV. Intraperitoneal macrophages isolated from mice were cultured and, 48 hours post-infection with H37Rv and H37Rv/ARPC4 strains at
10 MOI, were surface-stained with anti-CD11B and PD1 antibodies and samples were acquired by flow cytometry. Data shown here are representative
of three independent experiments. b) Cell death in H37Rv and H37Rv/ARPC4 Mtb infected macrophages. Intraperitoneal macrophages isolated from
mice were cultured and, 48 hours post-infection with H37Rv and H37Rv/ARPC4 strains in 1:10 ratio, were surface-stained with anti-CD11B, CD11C
antibodies followed by PI staining for 20 minutes prior to acquisition by flow cytometry to assess cell death in infected macrophages. The percentage
of cells expressing PI among CD11B6cells is shown with mean6STDEV. Data shown here are representative of three independent experiments. c)
Expression of macrophage activation markers. Intraperitoneal macrophages isolated from mice were cultured and, 48 hours post-infection with
H37Rv and H37Rv/ARPC4 strains at 10 MOI, were surface-stained with anti-CD11B, CD11C, MHCII, CD14, CD54, CD80, CD86 and CD69 antibodies and
samples were acquired by flow cytometry. CD11B+ cells were gated for expression of MHCII, CD14, CD54, CD80 and CD86 and the percentage of cells
expressing these markers are shown in the histogram overlay plots with mean6STDEV. Data shown here are representative of three independent
experiments. B. Confocal Microscopy images showing that H37Rv/ARPC4 mycobacterial strain is less infectious and persistent in macrophage. FITC-
labelled mycobacterial cells (green) were used for infecting macrophages (red) at an MOI of 5. At specific time-points, the cells were fixed,
permeabilized and stained with anti-LAMP1 antibodies, followed by Alexa Fluor 594 goat anti-rat antibodies. (a)- (d) shows the infected macrophage
cells at 0, 24, 48 and 72 hours’ time-points post-infection, respectively. (e) and (f) are the graphical representation of the percentage of macrophage
cells infected with FITC-labeled mycobacteria at different time-points and the percentage of bacteria localized in lysosomes in the infected cells,
respectively. Experiments were repeated thrice and similar results were obtained.
doi:10.1371/journal.pone.0069949.g003
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Figure 4. Rv1626-ARPC4 protein-protein interaction by bacterial two-hybrid. A. Bacterial two-hybrid plate showing Rv1626 and ARPC4
interaction where blue colored colonies show interaction between the bait and target proteins. BacterioMatch two-hybrid E. coli reporter strain was
co-transformed with Rv1626-pBTnn+ARPC4-pTRGnn; pBTnn+ARPC4-pTRGnn (negative control); LGF2-pBT+Gal11p-pTRG (positive control); and
Rv1626-pBTnn+Gal11p-pTRG (negative control) plasmids. Two individual colonies from each co-transformant were patched on X-gal indicator plate.
B. Histogram of liquid b-galactosidase assay for quantitative estimation of interaction strength of Rv1626 and ARPC4 compared to that with positive
and negative controls. Co-transformants ARPC4-pTRGnn+pBTnn and Gal11p-pTRG+Rv1626-pBTnn were taken as the negative controls; CFP10-
pTRGnn+ESAT6-pBTnn and Gal11p-pTRG+LGF2-pBT were taken as positive controls; and these were used to compare the b-galactosidase activity of
co-transformant ARPC4-pTRGnn+Rv1626-pBTnn. Enzyme activity is a direct indication of the strength of interaction of the bait and target proteins
and, is expressed in terms of Miller Units. All interactions were found to be statistically significant by Student’s t-test (*, P,0.05).
doi:10.1371/journal.pone.0069949.g004
Figure 5. Rv1626-ARPC4 protein-protein interaction in vitro. A. Coomassie-stained purification gel of ARPC4-His6X. ARPC4-His6X protein was
purified under denaturing conditions on a Ni-NTA column. 15% SDS polyacrylamide gel showing purified C-terminal His-tagged ARPC4 protein,
stained with coomassie blue. Lane 1: uninduced cell lysate, Lane 2: induced cell lysate, Lane 3: supernatant fraction of cell lysate (load), Lane 4: final
wash, Lane 5: low molecular weight protein marker (the sizes, in kDa, are indicated on the left of the panel), Lane 6–7: purified protein elution
fractions. B. Coomassie-stained purification gel of GST-Rv1626 proteins GST-Rv1626 protein was purified under native conditions on a Glutathione
Sepharose-4B resin column. 15% SDS polyacrylamide gel showing the purified GST-Rv1626 protein, stained with coomassie blue. Lane 1: uninduced
cell lysate, Lane 2: induced cell lysate, Lane 3–7 (except 4) are fractions collected from the column; Lane 3: wash fraction, Lane 4: low molecular
weight protein marker (the sizes, in kDa, are indicated on the left of the panel), Lane 5–7: purified protein elution fractions. C. Dot Far-Western Blots
showing in vitro protein-protein interactions. 1 mg each of purified ARPC4-His6X, GST, GST-Rv1626 or BSA proteins were immobilized on nitrocellulose
strips that were incubated overnight in 1 mg/mL solution of the either GST-Rv1626 or GST protein. The strips were then developed using the antibody
indicated in the parenthesis.
doi:10.1371/journal.pone.0069949.g005
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direct cell to cell spread by inducing actin polymerization through
recruitment of host cytoskeletal factors viz. Arp2/3 and WASP
(Wiskott Aldrich Syndrome Protein). The mycobacterial factor(s)
involved in this, though, still remain unknown [29,30]. In case of
M. tuberculosis, the long-held belief of the pathogen’s confinement
in phagosomes was challenged by reports clearly showing Mtb free
in the cytoplasm of the infected cell and capable of direct cell to
cell spread in tissue culture [31–34]. The mycobacterial factors
involved in this function are yet to be elucidated. The interaction
of mycobacterial Rv1626 with human Arp2/3, could form the
premise of this missing link.
Moreover, the discovery that a natural protein, i.e. ARPC4,
whose crystal structure is already known, interacts strongly with an
essential mycobacterial protein, could become a starting point for
peptidomimetic studies with the singular aim of finding anti-TB
molecules. Structural analyses could shed light on the interaction
interface of the two proteins, making ARPC4 a convenient
peptidomimetic template for further studies. The search for newer
drugs against this dreaded pathogen is an urgent one, and with the
sparse success achieved through compound library-based ap-
proaches, the area of peptidomimetics has over recent years gained
added importance. A closer inspection of the ARPC4-Rv1626
interaction may become a starting point for creating a library of
small molecules that are able to inhibit the functions of Rv1626.
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